Professional Documents
Culture Documents
PT - 503
PT - 503
PT - 503
p:/
htt
Name :
Roll No. : ...
Invigilator's Signature : .
CS/B.Pharm (New)/SEM-5/PT-503/2011-12
2011
PHARMACEUTICAL CHEMISTRY ( MEDICINAL )
Time Allotted : 3 Hours
Full Marks : 70
pap
wb
er.
GROUP A
( Multiple Choice Type Questions )
1.
5018 ( N )
in
a c.
ut .
i)
a)
Doxylamine
b)
c)
Medrylamine
d)
Triprolidine
Meclizine.
[ Turn over
CS/B.Pharm (New)/SEM-5/PT-503/2011-12
Benzhydryl bromide when treated with 2-dimethyl
/q
p:/
htt
ii)
b)
c)
d)
pap
iii)
a)
3-Acetamidophenyl-o-acetyl salicylate
b)
4-acetamidophenyl-o-acetyl salicylate
c)
d)
3-acetamidophenyl-o-acetyl salicylate.
in
a c.
ut .
5018 ( N )
wb
er.
iv)
a)
phenyl acetonitrile
b)
methyl salicylate
c)
4-hydroxy propiophenone
d)
mesitylene derivative.
CS/B.Pharm (New)/SEM-5/PT-503/2011-12
IUPAC system of nomenclature for diclophenac sodium
( BP ) is
/q
p:/
htt
v)
a)
phenyl
phenyl
acetate.
b)
d)
pap
vi)
c)
vii)
a)
Pyrrole
c)
Oxazole
wb
er.
Pyrimidine
d)
Pyridine.
b)
c)
d)
Pyrazolidinedione derivatives.
in
a c.
ut .
a)
5018 ( N )
a)
abolished
b)
c)
increased
d)
same
decreased.
[ Turn over
CS/B.Pharm (New)/SEM-5/PT-503/2011-12
Which one of the following has a bicyclic nucleus in its
/q
p:/
htt
ix)
structure ?
x)
a)
Clidinium bromide
b)
Pyridostigmine
c)
Echothiophate iodide
d)
Tropicamide.
pap
N-acetyl-p-benzoquinoneimine
b)
N-propyl-p-benzoquinoneimine
c)
N-methyl-p-benzoquinoneimine
d)
N-aryl-p-benzoquinoneimine.
wb
er.
xi)
a)
5018 ( N )
Ionic bonding
b)
Hydrogen bonding
c)
Covalent bonding
d)
in
a c.
ut .
xii)
a)
Diclofenac
b)
c)
Indomethacin
d)
4
Naproxen
Ibuprofen.
CS/B.Pharm (New)/SEM-5/PT-503/2011-12
/q
p:/
htt
GROUP B
( Short Answer Type Questions )
Answer any three of the following.
Ar1
2.
The structure
5 = 15
R1
( CH 2 ) n
Ar2
N
R2
is common to most of
pap
3.
4.
a)
Rofecoxib
iii)
Celecoxib.
c)
ii)
wb
er.
b)
Analgin
6.
in
a c.
ut .
5.
GROUP C
( Long Answer Type Questions )
15 = 45
a)
b)
5018 ( N )
[ Turn over
CS/B.Pharm (New)/SEM-5/PT-503/2011-12
Discuss
the
application
/q
p:/
htt
c)
of
QSAR
in
medicinal
chemistry.
8.
d)
e)
pap
b)
Aspirin
Discuss
ii)
the
wb
er.
9.
1+6+3+3+2
Mefenamic acid
structure-activity
iii) Paracetamol.
relationship
of
in
a c.
ut .
the advantages of selective COX2 inhibitors over nonselective NSAIDs. Is there any limitation for the use of
selective COX2 inhibitors ?
(3
2)+6+3
4+6+2+3
CS/B.Pharm (New)/SEM-5/PT-503/2011-12
Write down the metabolic pathways of histamine.
/q
p:/
htt
11. a)
b)
antagonists inhibit
the
c)
ii)
Meclizine
iii)
Promethazine.
pap
i)
5+5+5
wb
er.
in
a c.
ut .
5018 ( N )
[ Turn over